Literature DB >> 30354288

Use of Ablation Index-Guided Ablation Results in High Rates of Durable Pulmonary Vein Isolation and Freedom From Arrhythmia in Persistent Atrial Fibrillation Patients: The PRAISE Study Results.

Ahmed Hussein1, Moloy Das2, Stefania Riva3, Maureen Morgan1, Christina Ronayne1, Ankita Sahni1, Matthew Shaw1, Derick Todd1, Mark Hall1, Simon Modi1, Andrea Natale4, Antonio Dello Russo3, Richard Snowdon1, Dhiraj Gupta1.   

Abstract

Background Catheter ablation for persistent atrial fibrillation (AF) is associated with less favorable outcomes than for paroxysmal AF. Substrate modification is often added to pulmonary vein isolation (PVI) to try to improve success rates. Recent studies have shown improved clinical outcomes with use of regional ablation index (AI) targets for PVI. We hypothesized that prospective use of AI-guided PVI in persistent AF patients would result in a low rate of PV reconnection at repeat electrophysiology study and that a high success rate can be achieved with durable PVI alone. Methods Forty consecutive patients with persistent AF underwent AI-guided PVI with target values of 550 for anterior and 400 for posterior left atrial regions, followed by a protocol-mandated repeat procedure after 2 months. Patients were monitored for atrial tachyarrhythmia recurrence via daily plus symptom-initiated ECG recordings for 12 months. Recurrence was defined as ≥30 seconds of any atrial tachyarrhythmia after a 3-month blanking period. Results PV reconnection was seen at repeat electrophysiology study in 22% of patients, affecting 7% of PVs. Ablation on the intervenous carina was required in 44% patients to achieve durable PVI. Atrial tachyarrhythmia recurrence was documented in 8 (20%) patients, only one of whom had PV reconnection at repeat study. At 12 months, 38/40 (95%) patients were in sinus rhythm, with 4 (10%) patients having started antiarrhythmic drugs. Higher body mass index and excess alcohol consumption were the only significant factors associated with atrial tachyarrhythmia recurrence. Conclusions Use of AI targets results in a high level of durable PVI. A good clinical outcome can be achieved in the great majority of persistent AF patients with AI-guided PVI alone. Clinical Trial Registration URL: https://www.clinicaltrials.gov . Unique identifier: NCT02628730.

Entities:  

Keywords:  ablation index; atrial fibrillation; body mass index; catheter ablation; pulmonary veins

Mesh:

Year:  2018        PMID: 30354288     DOI: 10.1161/CIRCEP.118.006576

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  43 in total

1.  An ablation index operator-independent approach to improve efficacy in atrial fibrillation ablation at 24-month follow-up: a single center experience.

Authors:  Michela Casella; Antonio Dello Russo; Stefania Riva; Valentina Catto; Gabriele Negro; Rita Sicuso; Selene Cellucci; Alessio Gasperetti; Martina Zucchetti; Valentina Ribatti; Viviana Biagioli; Gaetano Fassini; Luigi Di Biase; Andrea Natale; Claudio Tondo
Journal:  J Interv Card Electrophysiol       Date:  2019-07-16       Impact factor: 1.900

2.  Pulmonary vein isolation using Ablation Index improves outcome in patients with atrial fibrillation.

Authors:  Jonas Elmer Pedersen; Kim Frost Lauritsen; Jens Brock Johansen; Niels Christian Foldager Sandgaard; Jorgen Dalhoj; Stig Djurhuus; Jacob Pontoppidan
Journal:  J Atr Fibrillation       Date:  2020-04-30

Review 3.  [Catheter ablation : Developments and technique selection].

Authors:  L Yahsaly; J Siebermair; R Wakili
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2022-02-18

4.  The effect of left atrial wall thickness and pulmonary vein sizes on the acute procedural success of atrial fibrillation ablation.

Authors:  Melinda Boussoussou; Bálint Szilveszter; Borbála Vattay; Márton Kolossváry; Milán Vecsey-Nagy; Zoltán Salló; Gábor Orbán; Perge Péter; Piros Katalin; Nagy Klaudia Vivien; Osztheimer István; Pál Maurovich-Horvat; Béla Merkely; László Gellér; Nándor Szegedi
Journal:  Int J Cardiovasc Imaging       Date:  2022-02-09       Impact factor: 2.357

Review 5.  Atrial fibrillation ablation strategies and technologies: past, present, and future.

Authors:  Thomas J Buist; Douglas P Zipes; Arif Elvan
Journal:  Clin Res Cardiol       Date:  2020-10-22       Impact factor: 5.460

Review 6.  Catheter ablation for atrial fibrillation: current indications and evolving technologies.

Authors:  Ramanathan Parameswaran; Ahmed M Al-Kaisey; Jonathan M Kalman
Journal:  Nat Rev Cardiol       Date:  2020-10-13       Impact factor: 32.419

7.  Radiofrequency Versus Cryoballoon Catheter Ablation for Paroxysmal Atrial Fibrillation: Durability of Pulmonary Vein Isolation and Effect on Atrial Fibrillation Burden: The RACE-AF Randomized Controlled Trial.

Authors:  Samuel K Sørensen; Arne Johannessen; René Worck; Morten L Hansen; Jim Hansen
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-04-09

8.  Optimizing Durability in Radiofrequency Ablation of Atrial Fibrillation.

Authors:  Zain I Sharif; E Kevin Heist
Journal:  J Innov Card Rhythm Manag       Date:  2021-05-15

9.  Characterizing clinical outcomes and factors associated with conduction gaps in VISITAG SURPOINT-guided catheter ablation for atrial fibrillation.

Authors:  Koichi Inoue; Nobuaki Tanaka; Yusuke Ikada; Akihiro Mizutani; Kazuhiko Yamamoto; Hana Matsuhira; Shinichi Harada; Masato Okada; Katsuomi Iwakura; Kenshi Fujii
Journal:  J Arrhythm       Date:  2021-05-07

10.  Local catheter impedance drop during pulmonary vein isolation predicts acute conduction block in patients with paroxysmal atrial fibrillation: initial results of the LOCALIZE clinical trial.

Authors:  Moloy Das; Armin Luik; Ewen Shepherd; Matthew Sulkin; Jacob Laughner; Tobias Oesterlein; Elizabeth Duffy; Christian Meyer; Pierre Jais; Josselin Duchateau; Arthur Yue; Waqas Ullah; Pablo Ramos; Ignacio García-Bolao
Journal:  Europace       Date:  2021-07-18       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.